🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Abbott boosts quarterly dividend to 59 cents, up 7.3%

Published 14/12/2024, 05:06 am
© Reuters.
ABT
-

Abbott Laboratories (NYSE:ABT), a company with a long-standing history of providing dividends to its shareholders, has announced an increase in its quarterly dividend.

The healthcare giant has been consistent in its dividend payments for more than a century, demonstrating resilience through various market conditions and significant historical events.

In a continuation of this tradition, Abbott has declared a 7.3% rise in its dividend, which will now stand at 59 cents per quarter.

This increase is a part of the company's ongoing commitment to dividend growth, which has seen the quarterly dividend rise by over 60% since 2020. Over the past ten years, the dividend has more than doubled.

The announcement signifies the company's 53rd consecutive year of dividend growth. Furthermore, it marks the 404th consecutive quarterly dividend paid by Abbott.

The company's consistent performance has secured its place in the S&P 500’s Dividend Aristocrats Index, which includes companies that have raised their dividend payout for at least 25 consecutive years.

Additionally, Abbott is recognized as one of the "Dividend Kings," a select group of companies that have increased their dividends for at least 50 years in a row.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.